The CDC's Diabetes Prevention Program is one of the first lifestyle- and behavior-based interventions to be proven, in a large clinical study, to be more effective than a comparable drug (in this case metformin). Digital implementations can make the DPP more accessible and more scalable, and a number of digital health companies have been tackling this for the last few years.
Fruit Street Health...
New top-line data presented by Omada Health and researchers from the University of Nebraska Medical Center and Wake Forest University suggest that the chronic condition-management company's digital diabetes-prevention program can deliver clinically meaningful blood sugar reduction and weight loss over 12 months.
The PREDICTS randomized controlled trial was first announced in 2018, and enrolled...
A retrospective analysis of more than 2,000 Livongo Diabetes Prevention Program (DPP) participants found an average weight loss of 5.1% from baseline after 12 months, and 6.6% among those who designated as high engagers.
The study, conducted by Livongo and published in BMJ Open Diabetes Research & Care, honed in on the relationships between specific program behaviors and program engagement...
A sample of low-income patients engaged with Omada Health’s digital diabetes prevention program (DPP), achieved weight loss but no major difference in HbA1c levels after a year of use, according to study data recently highlighted by the company.
The results — published late last year in the CDC’s Preventing Chronic Disease journal and first previewed at a 2018 public health conference — suggest...
Employer health tech company Virgin Pulse has its eyes set on the diabetes space with the recent acquisition of digital therapeutic Blue Mesa Health, best known for its diabetes prevention program Transform. The financial details of the deal were not released.
Following the announcement, Blue Mesa Health’s technology will now be rolled into a new offering called Virgin Pulse Transform. The...
This morning Solera Health, a digital marketplace for benefits and chronic disease management programs, is offering a new Diabetes Prevention Program (DPP) in American Sign Language (ASL) to people in the Kansas City area.
The program, created by the Johnson County Department of Health and Environment, will service adults living with hearing impairments in the region who are covered by a local...
San Francisco-based digital chronic disease management company Omada Health has closed a $73 million funding round led by Wellington Management Company. Cigna Ventures, Andreessen Horowitz, U.S. Venture Partners, Norwest Venture Partners, Kaiser Permanente Ventures, Sanofi Ventures, Civilization Ventures and Providence Ventures also contributed.
WHAT THEY DO
Omada offers a slew of digital...
Solera Health, a digital marketplace for benefit and chronic disease management programs, has raised $42 million in a Series C round led by Health Care Service Corporation subsidy HCSC Ventures. Prior backers BlueCross BlueShield Venture Partners/Sandbox Advantage Fund, Adams Street Partners and SJF Ventures participated as well.
WHAT THEY DO
Solera’s platform hosts a broad selection of digital...
De Novo clearance for urinary incontinence wearable. The FDA has granted De Novo clearance to Atlantic Therapeutics’ Innovo therapy device, an externally worn electrical muscle stimulator for the treatment of stress urinary incontinence. The wearable is intended for adult women as a front-line or second-line therapy, and in a multi-center randomized controlled trial recorded an 87 percent rate of...
Health2047, a technology innovation enterprise backed the American Medical Association, announced today the launch of its second spin out company. Called First Mile Care, the new entity will use its $2 million in seed funding to build a scalable platform for connecting people with prediabetes to coaches and demographic-appropriate behavior change guidance.
First Mile Care’s platform is being...
